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Increasingly trial results are fed back to participants and
their families, but there is little research about this pro-
cess if the participant dies. This issue was explored in
the BRACELET Study (Bereavement and Randomised
Controlled Trials) (http://www.bracelet-study.org.uk).
We conducted 30 interviews with 51 bereaved parents
of babies who were entered into one of five neonatal
intensive care trials, and 58 clinicians and/or trial team
members.
Bereaved parents expressed a range of views but
almost unanimously supported offering parents trial
results. Results were important for information, but also
as an acknowledgement of loss and contributions to
research, as connections to their baby and for commem-
oration and consolation. Parents thought that feedback
w o u l dh e l pt h e mf e e lt h a tt h e i rb a b yw a sn o tf o r g o t t e n
but valued as an individual, conferring meaning to a
short life.
Feedback is however not straightforward. Trials may
take a long time to recruit, analyse and report results.
Parental circumstances can change over time: those disin-
clined to consider receiving results at an earlier stage of
bereavement may change their views; those initially inter-
ested may become less so. The capacity of a trial team to
respond may also change: dedicated trial staff may no
longer be in post, funds for feedback may be limited and
parental addresses may no longer be current.
Further careful studies of feedback of results are
needed in a variety of trial settings to understand how
trial teams manage this situation, and to explore how
results are received and understood by both bereaved
and non-bereaved families.
Authors’ details
1Medical Statistics Department, London School of Hygiene and Tropical
Medicine, London, UK.
2National Perinatal Epidemiology Unit, University of
Oxford, Oxford, UK.
3Institute for Women’s Health, University College London,
London, UK.
4Department of Neurology, and Anaesthesia (Pediatrics),
Harvard Medical School, Boston, USA.
5Newcastle Neonatal Service, Royal
Victoria Infirmary, Newcastle-upon-Tyne, UK.
Published: 29 November 2013
doi:10.1186/1745-6215-14-S1-O32
Cite this article as: Snowdon et al.: Feeding back the results of trials to
the families of participants who have died: methodological
considerations from the bracelet study (bereavement and randomised
controlled trials). Trials 2013 14(Suppl 1):O32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
1Medical Statistics Department, London School of Hygiene and Tropical
Medicine, London, UK
Full list of author information is available at the end of the article
Snowdon et al. Trials 2013, 14(Suppl 1):O32
http://www.trialsjournal.com/content/14/S1/O32 TRIALS
© 2013 Snowdon et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.